Sign In
Buy ZLAB
$17.17
+0.0200 (+0.117%)
At Close: Jun 03, 2026
These stocks soared during the pandemic, and then crashed. Ten are now expected to double in price.
11:00am, Wednesday, 04'th May 2022 MarketWatch
The group rose at least 300% in the pandemic before crashing 70% or more.
Zai Lab to Announce First Quarter 2022 Financial Results on May 10, 2022
11:30am, Wednesday, 20'th Apr 2022 GlobeNewswire Inc.
-- Company to Host Conference Call and Webcast on May 11, 2022, at 8:00 a.m. ET -- Company to Host Conference Call and Webcast on May 11, 2022, at 8:00 a.m. ET
Zai Lab to Announce First Quarter 2022 Financial Results on May 10, 2022
07:30am, Wednesday, 20'th Apr 2022
-- Company to Host Conference Call and Webcast on May 11, 2022, at 8:00 a.m. ET -- Company to Host Conference Call and Webcast on May 11, 2022, at 8:00 a.m. ET
Zai Lab to Present New Oncology Research at 2022 AACR Annual Meeting
12:01pm, Wednesday, 06'th Apr 2022 GlobeNewswire Inc.
- First preview of preclinical data for ZL-1218, an anti-CCR8 antibody, in an oral presentation
Zai Lab to Present New Oncology Research at 2022 AACR Annual Meeting
08:01am, Wednesday, 06'th Apr 2022
- First preview of preclinical data for ZL-1218, an anti-CCR8 antibody, in an oral presentation
Most Chinese Biotech Stocks Can Continue US Listing After New Audit Framework
02:31pm, Friday, 01'st Apr 2022
According to a Bloomberg report, U.S. regulators could reportedly have full access to auditing reports from most of the 200-plus China-based companies listed in New York in mid-2022. In the drafting
Which Chinese Stocks Will Be Delisted? 8 in U.S. Crosshairs
06:25am, Monday, 28'th Mar 2022
Weibo Corp (WB), on Wednesday, joined previously identified Chinese stocks that may be delisted from U.S. exchanges. More could follow and Alibaba (BABA) could be in SEC crosshairs too.
SEC-targeted Chinese companies slump; Yum China warns of 2024 delisting risk
02:26pm, Saturday, 26'th Mar 2022 MarketWatch
All five companies fell in U.S. trading Thursday after the U.S. Securities and Exchange Commission put up a provisional list of companies that could be delisted if they don't measure up to U.S. accoun
Dow Jones Newswires: SEC-targeted Chinese companies slump; Yum China warns of 2024 delisting risk
11:26am, Saturday, 26'th Mar 2022
Shares of Chinese companies flagged for possible delisting in the U.S. slid in Hong Kong and Shanghai trading Friday, a move that analysts said highlighted geopolitical tensions but would have little
Which Chinese Stocks Could Get Delisted? 6 Companies to Watch.
02:53pm, Friday, 25'th Mar 2022
Today, news that Weibo has been added to the SEC's list of at-risk companies for delisting has investors selling Chinese stocks in a big way. The post Which Chinese Stocks Could Get Delisted?
Zai Lab Announces Change to Virtual Extraordinary General Meeting of Shareholders to be Held on March 28, 2022
11:30am, Wednesday, 23'rd Mar 2022 GlobeNewswire Inc.
SHANGHAI and SAN FRANCISCO, and CAMBRIDGE, Mass., March 23, 2022 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a patient-focused, innovative, commercial-stage, global biopharmaceut
Zai Lab Presents Positive Results from Phase 3 PRIME Study of ZEJULA® (Niraparib) at Society of Gynecologic Oncology Meeting
12:00am, Monday, 21'st Mar 2022 GlobeNewswire Inc.
SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., March 20, 2022 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a patient-focused, innovative, commercial-stage, global biopharmaceuti
Josh Smiley to join Zai Lab as COO (NASDAQ:ZLAB)
11:41am, Tuesday, 15'th Mar 2022 Seeking Alpha
Zai Lab (ZLAB) has appointed Josh Smiley as its Chief Operating Officer ((COO)), effective August 1, 2022.Mr
Zai Lab Announces the Appointment of Josh Smiley as Chief Operating Officer
11:30am, Tuesday, 15'th Mar 2022 GlobeNewswire Inc.
SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., March 15, 2022 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a patient-focused, innovative, commercial-stage, global biopharmaceuti
The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb''s Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings
09:37pm, Sunday, 13'th Mar 2022 Benzinga
Biotech stocks pulled back for a second week running, as the Ukraine war cast its cloud on the broader market. Dwindling earnings news flow and company-specific developments served as catalysts during the week. Kala Pharmaceuticals, Inc. (NASDAQ: KALA ) was among the biggest gainers of the week. The stock moved out of penny stock territory after the company announced UnitedHealth Incorporated (NYSE: UNH ) added Eysuvis 0.25% as a covered brand on its commercial formularies, effective March 2022. China-based biopharma companies Zai Lab Ltd. (NASDAQ: ZLAB ), BeiGene Ltd. (NASDAQ: BGNE ) and Hutchmed China Ltd (NASDAQ: HCM ) came under selling pressure after the SEC included these companies in the list of companies facing delisting threat. Here are the key catalysts that could move stocks in the unfolding week: Conferences World Sleep Congress, or WSC, 2022: March 11-16, in Rome, Italy Muscular Dystrophy Association (MDA) Clinical & Scientific Conference (hybrid event): March 13-16 Roth 34th Annual Healthcare Conference: March 14 Oppenheimer Virtual Annual Healthcare Conference: March 15-16 Barclays Global Healthcare Conference: March 15-17, in Miami, Florida AD/PD 2022: International Conference On Alzheimer''s And Parkinson''s Diseases And Related Neurological Disorders: March 15-22, in Barcelona, Spain 1st Annual Needham Virtual Neuroscience Forum: March 16 Guggenheim Virtual Healthcare Talks - Targeted Protein Degradation Day: March 16 American Society for Clinical Pharmacology & Therapeutics, ASCPT, Annual Meeting: March 16-18 Society of American Gastrointestinal And Endoscopic Surgeons, or SAGES, 2022 Annual Meeting: March 16-19, in Denver, Colorado American Pain Society, or APS, Annual Scientific Meeting: March 17-20, in Scottsdale, Arizona Society of Gynecologic Oncology, or SGO, Annual Meeting on Women''s Cancer: March 19-22, in Phoenix, Arizona European Group for Blood and Marrow Transplantation, or EBMT, Annual Congress: March 19-23, in Prague, Czech Republic PDUFA Dates The Food and Drug …
